Literature DB >> 17032382

Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 hours or more after stroke symptom onset: clinical and imaging features.

Angelica Perez1, Lucas Restrepo, Jonathan T Kleinman, Peter Barker, Norman Beauchamp, Robert J Wityk.   

Abstract

BACKGROUND: Abnormalities in diffusion-weighted (DWI) and perfusion-weighted (PWI) magnetic resonance imaging (MRI) are thought to reflect the presence of brain tissue at risk for ischemic stroke. Many patients with acute ischemic stroke have a mismatch pattern in which the PWI volume is larger than the DWI lesion. This mismatch typically resolves over 24-48 hours. Little is known about the presence of DWI-PWI mismatch in later stages of stroke.
METHODS: This is a retrospective study of 122 patients admitted with a diagnosis of acute ischemic stroke who had DWI and PWI abnormalities on studies performed within 7 days of onset of symptoms. Patients were divided into two groups: those with MRI performed <48 hours and those with MRI performed >or=48 hours from onset of symptoms.
RESULTS: Among 42 patients with MRI performed >or=48 hours after onset of stroke symptoms, 15 of 42 (36%) showed a mismatch pattern, compared to 45 of 80 (56%) in the <48 hours group (P < 0.05). Most of the patients in the >or=48 hours group with mismatch had large artery occlusive disease and many had neurological fluctuations. A subset of these patients were treated with induced hypertension and showed clinical improvement.
CONCLUSIONS: Some patients have persistent DWI-PWI mismatch up to several days after stroke onset. Further studies are needed to determine if these patients should be candidates for reperfusion therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17032382     DOI: 10.1111/j.1552-6569.2006.00063.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  9 in total

Review 1.  [Mechanical recanalization].

Authors:  C Roth; P Papanagiotou; K Hartmann; W Reith
Journal:  Radiologe       Date:  2009-04       Impact factor: 0.635

2.  Perfluorocarbons enhance a T2*-based MRI technique for identifying the penumbra in a rat model of acute ischemic stroke.

Authors:  Graeme A Deuchar; David Brennan; Hugh Griffiths; I Mhairi Macrae; Celestine Santosh
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-26       Impact factor: 6.200

3.  Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update.

Authors:  Feng Chen; Yi-Cheng Ni
Journal:  World J Radiol       Date:  2012-03-28

Review 4.  Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.

Authors:  Stephan Lüders
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Arterial spin labeling imaging findings in transient ischemic attack patients: comparison with diffusion- and bolus perfusion-weighted imaging.

Authors:  Greg Zaharchuk; Jean-Marc Olivot; Nancy J Fischbein; Roland Bammer; Matus Straka; Jonathan T Kleinman; Gregory W Albers
Journal:  Cerebrovasc Dis       Date:  2012-09-19       Impact factor: 2.762

Review 6.  Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery.

Authors:  R R Moustafa; J-C Baron
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

7.  Massive pulmonary thromboembolism and stroke.

Authors:  Poobalan Naidoo; Richard Hift
Journal:  Case Rep Med       Date:  2011-09-28

8.  Persistent Target Mismatch Profile >24 Hours After Stroke Onset in DEFUSE 3.

Authors:  Søren Christensen; Michael Mlynash; Stephanie Kemp; Amarnath Yennu; Jeremy J Heit; Michael P Marks; Maarten G Lansberg; Gregory W Albers
Journal:  Stroke       Date:  2019-03       Impact factor: 10.170

9.  Perfusion imaging of the right perisylvian neural network in acute spatial neglect.

Authors:  Regine Zopf; Monika Fruhmann Berger; Uwe Klose; Hans-Otto Karnath
Journal:  Front Hum Neurosci       Date:  2009-08-03       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.